Showing results (1-10 of 297) with videos related to
Sort By:
Pageof 30
European Journal of Cancer (Oxford, England : 1990)|October 25, 2025
Potential alternative dosage strategies for patent-protected oral cancer drugsAustin Wesevich, Liam J Schmitt, Mark J RatainBlood Advances|April 3, 2025
Triaging acute chest syndrome clinical decision-making using bedside SaO2/FiO2 ratioAustin Wesevich, Megan Woelkers, Ayodeji Adegunsoye, et al.British Journal of Cancer|August 4, 2023
Interventional pharmacoeconomics for immune checkpoint inhibitors through alternative dosing strategiesAustin Wesevich, Daniel A Goldstein, Koosha Paydary, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2018
The Molecular Profiling Lottery: More Accuracy, Less Precision, and No CostMark J RatainNature Reviews. Clinical Oncology|August 6, 2014
Targeted therapies: redefining the primary objective of phase I oncology trialsMark J RatainCurrent Hematologic Malignancy Reports|July 25, 2023
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/LymphomaAdam S DuVall, Austin Wesevich, Richard A LarsonJournal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 6, 2023
Role-Specific Curricular Needs for Identification and Management of Immune-Related Adverse EventsAustin Wesevich, Gong He, Greg Tomczyk, et al.Pharmacogenomics|December 23, 2006
Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotypingFederico Innocenti, Mark J RatainClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Individualizing dosing of irinotecanMark J Ratain, Federico InnocentiCancer Chemotherapy and Pharmacology|April 1, 2022
Lurbinectedin-induced thrombocytopenia: the role of body surface areaApostolos Papachristos, Mark J RatainPageof 30